Epitope Analysis of Anti-SARS-CoV-2 Neutralizing Antibodies

• 作者: Jun-biao XUE Sheng-ce TAO
• 来源期刊: 当代医学科学（英文）
• 年，卷（期）: 2021,（6）
• 所属期刊栏目: SARS-COV-2 VACCINES AND COVID-19 COLUMN
• 页码范围: 1065-1074
• 页数: 10页
• 语种: 英文
• DOI: 10.1007/s11596-021-2453-8

摘要

Coronavirus disease 2019 is threatening thousands of millions of people around the world.In the absence of specific and highly effective medicines,the treatment of infected persons is still very challenging.As therapeutics,neutralizing antibodies(NAbs)have great potential.Many NAbs have been reported,and most target various regions on the receptor-binding domain of the spike(S)protein,or the N-terminal domain.Several NAbs and NAb cocktails have been authorized for emergency use,and more are in clinical trials or are under development.In this review,considering the angle of binding epitopes on the S protein,we summarize the functions and the underlying mechanisms of a set of well-recognized NAbs and provide guidance for vaccine design and the combinatorial use of these antibodies.In addition,we review the NAbs and NAb cocktails that have been approved for emergency use and discuss the effectiveness of these NAbs for combating severe acute respiratory syndrome coronavirus 2 mutants.